ÈÑÒÈÍÀ

Jakupec M.A.

Ñîàâòîðû: Keppler B.K., Íàçàðîâ À.À., Hartinger C.G., Arion V.B., Dyson P.J., Galanski M., Kandioller W., Hanif M., Groessl M., Severin K., Eichinger R.E., Mendoza-Ferri M.G., John R.O. ïîêàçàòü ïîëíîñòüþ..., Habala L., Slaby S., Berger I., Bartel C., Kuznetsov M.L., Legin A., Meier S.M., Yasemi A., Valiahdi S.M., Schmitt F., Stolyarova N., Tsybin Y.O., Risse J., Hejl M., Abramkin S.A., Egger A.E., Berger W., Casini A., Bednarski P.J., Biba F., Bytzek A., Dworak C., Klein F., Maruszak M., Mangrum J.B., Mendoza M.A., Rausch M., Muhammad H., Meelich K., Farrell N.P., Giester G., Graf v.K., Zava O., Juillerat-Jeanneret L., Kasser J.H., Jungwirth U., Skocic M.

16 ñòàòåé, 12 äîêëàäîâ íà êîíôåðåíöèÿõ

Êîëè÷åñòâî öèòèðîâàíèé ñòàòåé â æóðíàëàõ ïî äàííûì Web of Science: 646, Scopus: 701

IstinaResearcherID (IRID): 1449693

Äåÿòåëüíîñòü ñòèëü:  îáû÷íûé | ÃÎÑÒ | plain | abbrv | acm | alpha | amsalpha | amsplain | apalike | ieeetr | siam

• Ñòàòüè â æóðíàëàõ

  • • 2013 Influence of the p-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes
    • Hanif Muhammad, Meier Samuel, Nazarov Alexey, Risse Julie, Legin Anton, Casini Angela, Jakupec Michael A., Keppler Bernhard K., Hartinger Christian G.
    • â æóðíàëå Frontiers in Chemistry, òîì 1, ñ. 27 DOI
  • 
    • 2012 Maleimide-functionalised Organoruthenium Anticancer Agents for Tumour Targeting
    • Hanif M., Nazarov A.A., Legin A., Groessl M., Arion V.B., Jakupec M.A., Tsybin Y.O., Dyson P.J., Keppler B.K., Hartinger C.G.
    • â æóðíàëå Chemical Communications, èçäàòåëüñòâî Royal Society of Chemistry (United Kingdom), òîì 48, ñ. 1475-1477 DOI
  • 
    • 2011 From hydrolytically labile to hydrolytically stable Ru II-arene anticancer complexes with carbohydrate-derived co-ligands
    • Hanif M., Meier S.M., Kandioller W., Bytzek A., Hejl M., Hartinger C.G., Nazarov A.A., Arion V.B., Jakupec M.A., Dyson P.J., Keppler B.K.
    • â æóðíàëå Journal of Inorganic Biochemistry, èçäàòåëüñòâî Elsevier BV (Netherlands), òîì 105, ? 2, ñ. 224-231 DOI
  • 
    • 2010 (1 R,2 R,4 R)-4-Methyl-1,2-cyclohexanediamineoxalatoplatinum(II): A Novel Enantiomerically Pure Oxaliplatin Derivative Showing Improved Anticancer Activity in Vivo
    • Abramkin S.A., Jungwirth U., Valiahdi S.M., Dworak C., Habala L., Meelich K., Berger W., Jakupec M.A., Hartinger C.G., Nazarov A.A., Galanski M., Keppler B.K.
    • â æóðíàëå Journal of Medicinal Chemistry, èçäàòåëüñòâî American Chemical Society (United States), òîì 53, ? 20, ñ. 7356-7364 DOI
  • 
    • 2010 Osmium(II)-versus ruthenium(II)-arene carbohydrate-based anticancer compounds: Similarities and differences
    • Hanif M., Nazarov A.A., Hartinger C.G., Kandioller W., Jakupec M.A., Arion V.B., Dyson P.J., Keppler B.K.
    • â æóðíàëå Dalton Transactions, èçäàòåëüñòâî Royal Society of Chemistry (United Kingdom), òîì 39, ? 31, ñ. 7345-7352 DOI
  • 
    • 2009 From pyrone to thiopyrone ligands-rendering maltol-derived ruthenium(II)-arene complexes that are anticancer active in vitro
    • Kandioller W., Hartinger C.G., Nazarov A.A., Kuznetsov M.L., John R.O., Bartel C., Jakupec M.A., Arion V.B., Keppler B.K.
    • â æóðíàëå Organometallics, èçäàòåëüñòâî American Chemical Society (United States), òîì 28, ? 15, ñ. 4249-4251 DOI
  • 
    • 2009 Influence of the arene ligand, the number and type of metal centers, and the leaving group on the in vitro antitumor activity of polynuclear organometallic compounds
    • Mendoza-Ferri M.G., Hartinger C.G., Nazarov A.A., Eichinger R.E., Jakupec M.A., Severin K., Keppler B.K.
    • â æóðíàëå Organometallics, èçäàòåëüñòâî American Chemical Society (United States), òîì 28, ? 21, ñ. 6260-6265 DOI
  • 
    • 2009 Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: The impact of ligand-metal bond stability on anticancer activity in vitro
    • Kandioller W., Hartinger C.G., Nazarov A.A., Bartel C., Skocic M., Jakupec M.A., Arion V.B., Keppler B.K.
    • â æóðíàëå Chemistry - A European Journal, èçäàòåëüñòâî John Wiley & Sons Ltd. (United Kingdom), òîì 15, ? 45, ñ. 12283-12291 DOI
  • 
    • 2009 Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity
    • Mendoza-Ferri M.G., Hartinger C.G., Mendoza M.A., Groessl M., Egger A.E., Eichinger R.E., Mangrum J.B., Farrell N.P., Maruszak M., Bednarski P.J., Klein F., Jakupec M.A., Nazarov A.A., Severin K., Keppler B.K.
    • â æóðíàëå Journal of Medicinal Chemistry, èçäàòåëüñòâî American Chemical Society (United States), òîì 52, ? 4, ñ. 916-925 DOI
  • 
    • 2009 Tuning the anticancer activity of maltol-derived ruthenium complexes by derivatization of the 3-hydroxy-4-pyrone moiety
    • Kandioller W., Hartinger C.G., Nazarov A.A., Kasser J., John R., Jakupec M.A., Arion V.B., Dyson P.J., Keppler B.K.
    • â æóðíàëå Journal of Organometallic Chemistry, èçäàòåëüñòâî Elsevier BV (Netherlands), òîì 694, ? 6, ñ. 922-929 DOI
  • 
    • 2008 In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands
    • Berger I., Hanif M., Nazarov A.A., Hartinger C.G., John R.O., Kuznetsov M.L., Groessl M., Schmitt F., Zava O., Biba F., Arion V.B., Galanski M., Jakupec M.A., Juillerat-Jeanneret L., Dyson P.J., Keppler B.K.
    • â æóðíàëå Chemistry - A European Journal, èçäàòåëüñòâî John Wiley & Sons Ltd. (United Kingdom), òîì 14, ? 29, ñ. 9046-9057 DOI
  • 
    • 2008 Influence of the spacer length on the in vitro anticancer activity of dinuclear ruthenium arene compounds
    • Mendoza-Ferri M.G., Hartinger C.G., Eichinger R.E., Stolyarova N., Severin K., Jakupec M.A., Nazarov A.A., Keppler B.K.
    • â æóðíàëå Organometallics, èçäàòåëüñòâî American Chemical Society (United States), òîì 27, ? 11, ñ. 2405-2407 DOI
  • 
    • 2007 A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?
    • Berger I., Nazarov A.A., Hartinger C.G., Groessl M., Valiahdi S.M., Jakupec M.A., Keppler B.K.
    • â æóðíàëå ChemMedChem, èçäàòåëüñòâî Wiley - V C H Verlag GmbbH & Co. (Germany), òîì 2, ? 4, ñ. 505-514 DOI
  • 
    • 2005 Rational development of oxaliplatin analogues - Synthesis and preliminary structure-activity relationships
    • Galanski M., Habala L., Nazarov A.A., Jakupec M.A., Yasemi A., Slaby S., Graf v.Keyserlingk N, Keppler B.K.
    • â æóðíàëå International Journal of Clinical Pharmacology and Therapeutics, èçäàòåëüñòâî Dustri-Verlag Dr. Karl Feistle (Germany), òîì 43, ? 12, ñ. 575-576 DOI
  • 
    • 2004 Synthesis, crystal structure and cytotoxicity of new oxaliplatin analogues indicating that improvement of anticancer activity is still possible
    • Galanski M., Yasemi A., Slaby S., Jakupec M.A., Arion V.B., Rausch M., Nazarov A.A., Keppler B.K.
    • â æóðíàëå European Journal of Medicinal Chemistry, èçäàòåëüñòâî Elsevier BV (Netherlands), òîì 39, ? 8, ñ. 707-714 DOI
  • 
    • 2002 Novel glucose-ferrocenyl derivatives: Synthesis and properties
    • Hartinger C.G., Nazarov A.A., Arion V.B., Giester G., Jakupec M., Galanski M., Keppler B.K.
    • â æóðíàëå New Journal of Chemistry, èçäàòåëüñòâî Royal Society of Chemistry (United Kingdom), òîì 26, ? 6, ñ. 671-673 DOI

• Äîêëàäû íà êîíôåðåíöèÿõ

  • • 2012 Exploring Tumor Targeting Options for Treatment with Organometallic Agents (Óñòíûé)
    • Àâòîðû: Muhammad H., Andrea K., Meier S.M., Wolfgang K., Michael G.G., Íàçàðîâ À.À., Jakupec M.A., Dyson P.J., Nils M., Keppler B.K., Hartinger C.G.
    • 6th International Symposium on Bioorganometallic Chemistry, Toronto, Canada, Êàíàäà, 2012
  • • 2011 Selective Modification of Proteins with Maleimide-functionalized Ru(Arene) Complexes and their Tumor-inhibiting Properties (Óñòíûé)
    • Àâòîðû: Michael G.G., Íàçàðîâ À.À., Muhammad H., Jakupec M.A., Dyson P.J., Keppler B.K., Hartinger C.G.
    • 15th International Conference on Biological Inorganic Chemistry, Vancouver, Canada, Êàíàäà, 2011
  • • 2007 2,3-Diaminoglucose Platinum(II) Complexes: Synthesis, dGMP Binding and Cytotoxicity
    • Àâòîðû: Isabella B., Seied-M V., Michael G.G., Íàçàðîâ À.À., Hartinger C.G., Jakupec M.A., Keppler B.K.
    • 13th International Conference on Biological Inorganic Chemistry ICBIC-13, Vienna, Austria, Àâñòðèÿ, 2007
  • • 2007 Modulating the In Vitro Anticancer Activity of Multinuclear Ruthenium(II)? and Osmium(II)?Arene Complexes Based on Pyridinone Ligands
    • Àâòîðû: Natalya S., Franz K., Jakupec M.A., Hartinger C.G., Íàçàðîâ À.À., Kay S., Keppler B.K.
    • 13th International Conference on Biological Inorganic Chemistry ICBIC-13, Vienna, Austria, Àâñòðèÿ, 2007
  • • 2007 Synthesis and characterization of substituted 3-hydroxy-4-pyrones and their Ru(II)?Arene Complexes
    • Àâòîðû: Wolfgang K., Hartinger C.G., Íàçàðîâ À.À., Roland J., Jakupec M.A., Keppler B.K.
    • 13th International Conference on Biological Inorganic Chemistry ICBIC-13, Vienna, Austria, Àâñòðèÿ, 2007
  • • 2007 Synthesis, Hydrolytical Stability, and Biological Activity of Ru(II)?Arene Complexes Based on Bicyclophosphites of Glucofuranosides
    • Àâòîðû: Íàçàðîâ À.À., Isabella B., Florian B., Hartinger C.G., Roland J., Mangrum J.B., Farrell N.P., Markus G., Jakupec M.A., Keppler B.K.
    • 13th International Conference on Biological Inorganic Chemistry ICBIC-13, Vienna, Austria, Àâñòðèÿ, 2007
  • • 2007 Synthetic approaches towards new derivatives of the DACH ligand and their utilization in anticancer complexes of platinum
    • Àâòîðû: Ladislav H., Markus G., Íàçàðîâ À.À., Jakupec M.A., Arion V.B., Keppler B.K.
    • 13th International Conference on Biological Inorganic Chemistry ICBIC-13, Vienna, Austria, Àâñòðèÿ, 2007
  • • 2006 Dinuclear Ruthenium(II)? and Osmium(II)?Arene complexes as New Anticancer Agents
    • Àâòîðû: Mendoza-Ferri M.G., Íàçàðîâ À.À., Hartinger C.G., Jakupec M.A., Rene E., Mendoza M.A., Franz K., Kay S., Keppler B.K.
    • COST D20 Final Evaluation Meeting, Brno, Czech Republic , ×åõèÿ, 2006
  • • 2006 Synthesis and In Vitro Antitumor Activity of 2,3-Diaminoglucose-Based Platinum(II) Coordination Compounds
    • Àâòîðû: Berger I., Íàçàðîâ À.À., Hartinger C.G., Valiahdi S.M., Jakupec M.A., Galanski M., Keppler B.K.
    • 9th International Symposium in Biology and Medicine, Lisbon, Portugal, Ïîðòóãàëèÿ, 2006
  • • 2006 Synthesis, characterization and biological activity of Ru(II) arene complexes based on bicyclophosphites of glucofuranosides
    • Àâòîðû: Isabella B., Íàçàðîâ À.À., Hartinger C.G., Roland J., Jakupec M.A., Keppler B.K.
    • COST D20 Final Evaluation Meeting, Brno, Czech Republic , ×åõèÿ, 2006
  • • 2005 Crystal Structure, and Cytotoxicity of New Methyl-Substituted Oxaliplatin Analogues
    • Àâòîðû: Íàçàðîâ À.À., Markus G., Claudia D., Ladislav H., Hartinger C.G., Jakupec M.A., Mojtaba V.S., Von Keyserlingk N.G., Keppler B.K.
    • 12h International Conference on Biological Inorganic Chemistry ICBIC-12, Ann Arbor, USA, 2005
  • • 2004 Synthesys, cytotoxicity and structure-activity relationships of new oxaliplatin derivatives
    • Àâòîðû: Markus G., Ladislav H., Íàçàðîâ À.À., Christina R., Jakupec M.A., Afshin Y., Susanna S., Von Keyserlingk N.G., Keppler B.K.
    • 7th European Conference on Biological Inorganic Chemistry, Garmisch-Partenkirchen, Germany, Ãåðìàíèÿ, 2004